In an attempt to reverse the retinitis pigmentosa (RP) phenotype in an EYS (Eyes shut homolog)-associated RP zebrafish model, Schellens et al. [169] employed CRISPR/Cas9 technology to generate an excised form of the EYS gene. The gene discussed is EYS; the disease is retinitis pigmentosa 1.